|
1
|
Chen HM, Tsai CM, Wu YC, Lin KC and Lin
CC: Randomised controlled trial on the effectiveness of home-based
walking exercise on anxiety, depression and cancer-related symptoms
in patients with lung cancer. Br J Cancer. 112:438–445. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yun YH, Shon EJ, Yang AJ, Kim SH, Kim YA,
Chang YJ, Lee J, Kim MS, Lee HS, Zo JI, et al: Needs regarding care
and factors associated with unmet needs in disease-free survivors
of surgically treated lung cancer. Ann Oncol. 24:1552–1559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Welsh JW, Komaki R, Amini A, Munsell MF,
Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, et
al: Phase II trial of erlotinib plus concurrent whole-brain
radiation therapy for patients with brain metastases from
non-small-cell lung cancer. J Clin Oncol. 31:895–902. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schuette W, Krzakowski MJ, Massuti B,
Otterson GA, Lizambri R, Wei H, Berger DP and Chen Y: Randomized
phase II study of palifermin for reducing dysphagia in patients
receiving concurrent chemoradiotherapy for locally advanced
unresectable non-small cell lung cancer. J Thorac Oncol. 7:157–164.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takigawa N, Kiura K, Segawa Y, Hotta K,
Tamaoki A, Tokuda Y, Nagata T, Watanabe K, Gemba K, Moritaka T, et
al: Benefits and adverse events among elderly patients receiving
concurrent chemoradiotherapy for locally advanced non-small cell
lung cancer: Analysis of the Okayama Lung Cancer Study Group trial
0007. J Thorac Oncol. 6:1087–1091. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Hu YM, Du YJ, Zhu LR, Qian H, Wu Y
and Shi WL: Expressions of MUC1 and vascular endothelial growth
factor mRNA in blood are biomarkers for predicting efficacy of
gefitinib treatment in non-small cell lung cancer. BMC Cancer.
14:8482014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laack E, Scheffler A, Burkholder I,
Boeters I, Andritzky B, Schuch G, Görn M, Vohwinkel G, Edler L,
Fiedler W and Hossfeld DK: Pretreatment vascular endothelial growth
factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels
in patients with metastatic non-small cell lung cancer (NSCLC).
Lung Cancer. 50:51–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Takayama K, Wang S, Shiraishi Y,
Gotanda K, Harada T, Furuyama K, Iwama E, Ieiri I, Okamoto I and
Nakanishi Y: Addition of bevacizumab enhances antitumor activity of
erlotinib against non-small cell lung cancer xenografts depending
on VEGF expression. Cancer Chemother Pharmacol. 74:1297–1305. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng WJ, Zhang JQ, Wang BX, Pan HF, Lu MM
and Wang J: Prognostic value of matrix metalloproteinase 9
expression in patients with non-small cell lung cancer. Clin Chim
Acta. 413:1121–1126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siejka A, Barabutis N and Schally AV: GHRH
antagonist inhibits focal adhesion kinase (FAK) and decreases
expression of vascular endothelial growth factor (VEGF) in human
lung cancer cells in vitro. Peptides. 37:63–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Zhao SJ, Shi HL, Qiu SP, Xie JQ, Wu
H, Zhang BB, Wang ZT, Yuan JY and Wu XJ: Berberine hydrochloride
IL-8 dependently inhibits invasion and IL-8-independently promotes
cell apoptosis in MDA-MB-231 cells. Oncol Rep. 32:2777–2788. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang HY, Yu HZ, Huang SM and Zheng YL:
p53, Bcl-2 and cox-2 are involved in berberine
hydrochloride-induced apoptosis of HeLa229 cells. Mol Med Rep.
14:3855–3861. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li HL, Wu H, Zhang BB, Shi HL and Wu XJ:
MAPK pathways are involved in the inhibitory effect of berberine
hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8
secretion in vitro and in vivo. Mol Med Rep.
14:1430–1438. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh IP and Mahajan S: Berberine and its
derivatives: A patent review (2009-2012). Expert Opin Ther Pat.
23:215–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan W, Li Y, Chen M and Wang Y: Berberine
hydrochloride: Anticancer activity and nanoparticulate delivery
system. Int J Nanomedicine. 6:1773–1777. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Diogo CV, Machado NG, Barbosa IA, Serafim
TL, Burgeiro A and Oliveira PJ: Berberine as a promising safe
anti-cancer agent-is there a role for mitochondria? Curr Drug
Targets. 12:850–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and
Lim JS: Berberine-induced AMPK activation inhibits the metastatic
potential of melanoma cells via reduction of ERK activity and COX-2
protein expression. Biochem Pharmacol. 83:385–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu W, Du S and Wang J: Berberine inhibits
the proliferation of prostate cancer cells and induces
G0/G1 or G2/M phase arrest at
different concentrations. Mol Med Rep. 11:3920–3924. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamura M, Oda M, Matsumoto I, Tsunezuka Y,
Kawakami K, Ohta Y and Watanabe G: The combination assay with
circulating vascular endothelial growth factor (VEGF)-C, matrix
metalloproteinase-9, and VEGF for diagnosing lymph node metastasis
in patients with non-small cell lung cancer. Ann Surg Oncol.
11:928–933. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gridelli C, Rossi A, Di Maio M, Leo S,
Filipazzi V, Favaretto AG, Burgio MA, Cinieri S, Bianco R,
Ciardiello F, et al: Rationale and design of MILES-3 and MILES-4
studies: Two randomized phase 3 trials comparing single-agent
chemotherapy versus cisplatin-based doublets in elderly patients
with advanced non-small-cell lung cancer. Clin Lung Cancer.
15:166–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kentepozidis N, Kotsakis A, Soultati A,
Agelaki S, Christophylakis Ch, Agelidou M, Chelis L, Papakotoulas
P, Vamvakas L, Zafiriou Z, et al: Docetaxel plus cisplatin and
bevacizumab for untreated patients with advanced/metastatic
non-squamous non-small-cell lung cancer: A multicenter phase II
study of the Hellenic Oncology Research Group. Cancer Chemother
Pharmacol. 71:605–612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tan W, Zhong Z, Wang S, Suo Z, Yang X, Hu
X and Wang Y: Berberine regulated lipid metabolism in the presence
of C75, compound C, and TOFA in breast cancer cell line MCF-7. Evid
Based Complement Alternat Med. 2015:3960352015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ortiz Guamán LM, Croce AL, Aredia F,
Sapienza S, Fiorillo G, Syeda TM, Buzzetti F, Lombardi P and
Scovassi AI: Effect of new berberine derivatives on colon cancer
cells. Acta Biochim Biophys Sin (Shanghai). 47:824–833. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Q, Qin R, Fang Y and Li H: Berberine
sensitizes human ovarian cancer cells to cisplatin through
miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem.
36:956–965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang R, Ke ZF, Wang F, Zhang WH, Wang YF,
Li SH and Wang LT: GOLPH3 overexpression is closely correlated with
poor prognosis in human non-small cell lung cancer and mediates its
metastasis through upregulating MMP-2 and MMP-9. Cell Physiol
Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong QZ, Wang Y, Tang ZP, Fu L, Li QC,
Wang ED and Wang EH: Derlin-1 is overexpressed in non-small cell
lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated
up-regulation of MMP-2 and MMP-9. Am J Pathol. 182:954–964. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu SJ, Yin CX, Ding MC, Xia SY, Shen QM
and Wu JD: Berberine suppresses in vitro migration of human aortic
smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1,
and NF-kappaB. BMB Rep. 47:388–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cepeda MA, Evered CL, Pelling JJ and
Damjanovski S: Inhibition of MT1-MMP proteolytic function and
ERK1/2 signalling influences cell migration and invasion through
changes in MMP-2 and MMP-9 levels. J Cell Commun Signal.
11:167–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Andorfer P, Heuwieser A, Heinzel A, Lukas
A, Mayer B and Perco P: Vascular endothelial growth factor A as
predictive marker for mTOR inhibition in relapsing high-grade
serous ovarian cancer. BMC Syst Biol. 10:332016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Q, Zhang C, Yang X, Yang B, Wang J,
Kang Y, Wang Z, Li D, Huang G, Ma Z, et al: Berberine inhibits the
expression of hypoxia induction factor-1alpha and increases the
radiosensitivity of prostate cancer. Diagn Pathol. 9:982014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hrabec E, Strek M, Nowak D, Greger J,
Suwalski M and Hrabec Z: Activity of type IV collagenases (MMP-2
and MMP-9) in primary pulmonary carcinomas: A quantitative
analysis. J Cancer Res Clin Oncol. 128:197–204. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim YR and Hong SH: Association between
the polymorphisms of the vascular endothelial growth factor gene
and metabolic syndrome. Biomed Rep. 3:319–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sandler A, Hirsh V, Reck M, von Pawel J,
Akerley W and Johnson DH: An evidence-based review of the incidence
of CNS bleeding with anti-VEGF therapy in non-small cell lung
cancer patients with brain metastases. Lung Cancer. 78:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xie J, Xu Y, Huang X, Chen Y, Fu J, Xi M
and Wang L: Berberine-induced apoptosis in human breast cancer
cells is mediated by reactive oxygen species generation and
mitochondrial-related apoptotic pathway. Tumour Biol. 36:1279–1288.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu B, Li Y, Li H, Zhang Y, Xu J, Ren L, Fu
S and Zhou Y: Bax inhibitor-1 is overexpressed in non-small cell
lung cancer and promotes its progression and metastasis. Int J Clin
Exp Pathol. 8:1411–1418. 2015.PubMed/NCBI
|
|
36
|
Hansakul P, Aree K, Tanuchit S and Itharat
A: Growth arrest and apoptosis via caspase activation of
dioscoreanone in human non-small-cell lung cancer A549 cells. BMC
Complement Altern Med. 14:4132014. View Article : Google Scholar : PubMed/NCBI
|
